Center for Sarcoma and Connective Tissue Oncology
Mass General Cancer Center
55 Fruit Street
Boston, MA 02114
Support Sarcoma Research
Help our team at the Center for Sarcoma and Connective Tissue Oncology improve outcomes while providing extraordinary care to patients with sarcoma and musculoskeletal tumors. Make a gift.
Explore the Center for Sarcoma and Connective Tissue Oncology
The Center for Sarcoma and Connective Tissue Oncology at Massachusetts General Hospital Cancer Center specializes in the diagnosis and treatment of bone and soft tissue tumors, both malignant and benign. The team represents one of the largest sarcoma treatment groups in the country.
We offer comprehensive, multidisciplinary care for patients with:
- Clear Cell Sarcoma
- Desmoid Fibromatosis
- Dermatofibrosarcoma protuberans (DFSP)
- Desmoplastic Small Round Cell Tumor (DSRCT)
- Epithelioid Sarcoma
- Epithelioid Hemangioendothelioma (EHE)
- Ewings sarcoma
- Gastrointestinal stromal tumor (GIST)
- Kaposi’s sarcoma (KS)
- Leiomyosarcoma (LMS)
- Liposarcoma (LPS)
- Malignant Peripheral Nerve Sheath Tumor (MPNST)
- Peripheral Neuroectodermal Tumor (PNET)
- Pigmented Villonodular Synovitis (PVNS)
- Radiation associated sarcoma
- Spindle Cell Sarcoma
- Synovial sarcoma
- Tenosynovial Giant Cell Tumor (TGCT)
- Undifferentiated pleomorphic sarcoma (UPS)
Our patients also have access to The Harris Center for Chordoma Care, a specialized program at the Cancer Center dedicated to chordoma research and care.
Mass General Cancer Center's Adolescent and Young Adult (AYA) Cancer Program provides specialized resources and support for our AYA patients. Patients can access supportive care resources including social work, psychology, psychiatry, sexual health and fertility, lifestyle medicine, integrative therapies, and parenting guidance. Dedicated AYA clinicians and program manager are available to connect patients to these resources and answer any questions.
Multidisciplinary Patient Care
Because the treatment of these cancers is complex, highly specialized experts are needed to guarantee the best possible outcomes. Each patient in our program is cared for by a multidisciplinary team of experts who specialize in the diagnosis and treatment of sarcomas and connective tissue cancers. Each patient’s medical team works together throughout care and follow-up, ensuring a seamless continuity of care.
The Sarcoma/Oncology Computational Biology Laboratory conducts cancer genomic/bioinformatics studies in order to detect molecular patterns relevant to tumor outcome and response to conventional or novel treatments.
Meet the Team
Meet our multidisciplinary team of sarcoma specialists.
- Director, Sarcoma Oncology Program
- Associate Professor of Medicine, Harvard Medical School
- Investigator, Henri and Belinda Termeer Center for Targeted Therapies
- Assistant Professor of Medicine, Harvard Medical School
- Pediatric Surgeon
- Associate Program Director, MGH Surgical Residency Program
- Surgical Oncology
- Department of Surgery
- Visiting Surgeon, Department of Surgery
- Director, General Surgery Residency Program
- Orthopaedic Oncology Surgeon
- Assistant Professor of Orthopaedic Surgery, Harvard Medical School
- Orthopaedic Oncology Surgeon
- Instructor in Orthopaedic Surgery, Harvard Medical School
- Chief, Orthopaedic Oncology Service
- Director, Musculoskeletal Oncology Fellowship Program
- Associate Professor of Orthopaedic Surgery, Harvard Medical School
- Chief, Orthopaedic Spine Service
- Director, Spine Oncology & Co-Director, Stephan L. Harris Chordoma Center
- Associate Professor of Orthopedic Surgery, Harvard Medical School
- Department of Radiation Oncology
- Associate Professor, Harvard Medical School
Patient Education & Resources
This program addresses the unique needs of patients with cancer ages 15-39.
This program helps patients regain physical abilities and maintain independence.
View select publications from the Center for Sarcoma and Connective Tissue Oncology team.